Howe & Rusling Inc Aim Immuno Tech Inc. Put Options Transaction History
Howe & Rusling Inc
- $1.18 Billion
- Q1 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|---|---|---|---|---|
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
Others Institutions Holding AIM
# of Institutions
34Shares Held
4.8MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA2.44MShares$22.2 Million0.0% of portfolio
-
Black Rock Inc. New York, NY698KShares$6.35 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA531KShares$4.84 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny318KShares$2.89 Million0.0% of portfolio
-
State Street Corp Boston, MA173KShares$1.58 Million0.0% of portfolio
About AIM ImmunoTech Inc.
- Ticker AIM
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,049,300
- Market Cap $437M
- Description
- AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. The company's products include Ampligen, a drug of macromolecular ribonucleic acid molecules for the treatment of chronic fatigue syndrome...